EDGAR Filing Documents for 0001062993-23-003833

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001062993-23-003833

Filing Date

2023-02-16

Accepted

2023-02-16 18:20:01

Documents

Period of Report

2023-02-14

Document Format Files

Seq	Description	Document	Type	Size
1	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	form4.html	4
1	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	form4.xml	4	3998
	Complete submission text file	0001062993-23-003833.txt		5407

Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801

Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 (617)871-2101

Comera Life Sciences Holdings, Inc. (Issuer) CIK: 0001907685 (see all company filings)

IRS No.: 874706968 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801

Business Address

Type: 4 | Act: 34 | File No.: 001-41403 | Film No.: 23639756